TRAIL is involved in CpG ODN-mediated anti-apoptotic signals

Title
TRAIL is involved in CpG ODN-mediated anti-apoptotic signals
Author(s)
백석환임은정[임은정]박대원정태활[정태활]진병로배외식[배외식]
Keywords
TOLL-LIKE RECEPTORS; NF-KAPPA-B; INNATE IMMUNITY; TLR AGONISTS; INDUCTION; DNA; PATHWAYS; OLIGODEOXYNUCLEOTIDE; SUPPRESSION; INHIBITION
Issue Date
201204
Publisher
SPANDIDOS PUBL LTD
Citation
ONCOLOGY REPORTS, v.27, no.4, pp.1213 - 1218
Abstract
Synthetic oligodeoxynucleotides (ODNs) with the CpG-motifs are recognized by toll-like receptor 9 (TLR9), which elicits an immune response. Serum starvation of Raw264.7 cells increased tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression. However, treatment with CpG ODN reduced TRAIL expression as well as apoptosis by serum starvation. In serum starved cells, TLR9 inhibitors recovered the decreasing TRAIL expression and sub-G1 accumulation by CpG ODN. CpG ODN-regulated anti-apoptotic signals which were dependent on the Akt-FoxO3a signaling pathway. CpG ODNs activated Akt and inactivated FoxO3a in scrum starved cells. Knockdown of FoxO3a by siRNA decreased TRAIL expression and apoptosis in serum-starved cells. In contrast, FoxO3a overexpression increased apoptosis by serum starvation, and CpG ODNs blocked these effects through TRAIL expression. LY294002, a PI3K-Akt inhibitor, blocked the CpG ODN effect of TRAIL expression and the sub-G1 population in serum starved cells. In contrast, overexpression of wild-type Akt reduced additional sub-G1 cells both in non-CpG ODN- and CpG ODN-treated cells. Taken together, these results demonstrate the involvement of A kt-FoxO3a signaling in TLR9-mediated downregulation of TRAIL and anti-apoptotic signals.
URI
http://hdl.handle.net/YU.REPOSITORY/28624http://dx.doi.org/10.3892/or.2011.1579
ISSN
1021-335X
Appears in Collections:
의과대학 > 생화학.분자생물학교실 > Articles
의과대학 > 치과학교실 > Articles
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE